BMP4 and metabolic dysfunction-associated steatotic liver disease: Here, we demonstrated that exogenous BMP4 inhibited the hepatic steatosis, lowered serum triglyceride (TG) and body weight, and alleviated the development and progression of NAFLD in a mouse model.